|
|
|
|
|
|
|
|||
|
IRB Home |
Historic Research |
Federal Regulations |
Sladen Library |
Welcome Ethical Research Practice Institutional Review Board IRB Review Criteria Informed Consent Genetic Testing Continuation & Final Reports Serious Adverse Events Frequently Asked Questions Conclusion |
|
Genetic Testing Genetic
testing is the evaluation of a gene for abnormalities that may be inherited
and are associated with an increase in the risk for developing
specific diseases or abnormalities. The increased risk may be for the
subject or a relative of the subject tested. Testing for abnormal genes
that are
not associated with inherited traits (gene abnormalities associated with
cancer or with abnormal DNA content) does not fall under this category.
This category also covers tissue banking that might lead to genetic testing
at a later date (bone, blood, sperm). The potential implications of genetic
testing are related to confidentiality for the subjects now covered by
the strict guidelines of the HIPAA
Act. The
risks for subjects are related to risks such as insurance companies or
future employers gaining
access to information resulting
in denial of coverage or potential discrimination. As genetic testing
and alternative methods of treatment become more available, this area of
research is likely to become more complicated and require ethical scrutiny
from
all
involved in research.
<<< Back |
||